Sophie C. Kunte

Total Tumor Volume on 18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225Ac-PSMA-I&T

Lena M. Unterrainer, Leonie Beyer, Mathias J. Zacherl et al. · Biomedicines · 2022 · 25 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study

Mona Kafka, Andreas Horninger, Gianpaolo di Santo et al. · European Urology Oncology · 2023 · 23 citations · Full text

Medicine, Oncology, Urology +17

Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments

Katharina Müller, Robert Forbrig, Jonas Reis et al. · Neuro-Oncology · 2024 · 15 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis

Lena M. Unterrainer, Lennert Eismann, Simon Lindner et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · 14 citations · Full text

Medicine, Oncology, Surgery +14

PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [18F]SiTATE – first clinical experiences

Sophie C. Kunte, Vera Wenter, Johannes Toms et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · 13 citations · Full text

Medicine, Nuclear Medicine, Radiology +17